2013
DOI: 10.1016/j.molstruc.2013.03.004
|View full text |Cite
|
Sign up to set email alerts
|

Is the structural diversity of tripeptides sufficient for developing functional food additives with satisfactory multiple bioactivities?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(7 citation statements)
references
References 90 publications
0
7
0
Order By: Relevance
“…It has been shown that several potent ACE inhibitory or antioxidant short peptides (2 to 3 amino acid residues) were also bitter. 23,40,48,82 In contrast, in another study, 24 no direct correlation was seen between ACE inhibitory properties and bitterness of di-or tripeptides. The number of possible dipeptide combinations (20 2 ¼ 400) is lower than that of larger peptides, increasing the structural diversity of larger peptides.…”
mentioning
confidence: 79%
“…It has been shown that several potent ACE inhibitory or antioxidant short peptides (2 to 3 amino acid residues) were also bitter. 23,40,48,82 In contrast, in another study, 24 no direct correlation was seen between ACE inhibitory properties and bitterness of di-or tripeptides. The number of possible dipeptide combinations (20 2 ¼ 400) is lower than that of larger peptides, increasing the structural diversity of larger peptides.…”
mentioning
confidence: 79%
“…When compared to dipeptides, tripeptides were reported to exhibit higher levels of antioxidant activity [ 14 ]. Besides, tripeptides had much larger structural diversity than dipeptides, which is a good property for developing multifunctional food additives [ 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…The QlAIP set was recently complied by Wang et al.,30 which was a collection of antihypertensive peptides in varied sequence lengths, consisting of 23 dipeptides, 23 tripeptides, 13 tetrappetides, 12 pentapeptides, 15 hexapeptides and 32 longer peptides. The antihypertensive potency of these peptides was measured in vivo by the decrease (mm Hg) in systolic blood pressure (SBP) of hypertensive rats (SHRs) administered with corresponding peptides.…”
Section: Methodsmentioning
confidence: 99%